Panacea Biotec Limited (BOM:531349)

Market Cap	26.71B
Revenue (ttm)	5.59B
Net Income (ttm)	-83.70M
Shares Out	n/a
EPS (ttm)	-1.37
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,080
Average Volume	16,214
Open	427.00
Previous Close	424.90
Day's Range	417.20 - 447.10
52-Week Range	129.65 - 581.00
Beta	n/a
RSI	51.16
Earnings Date	Aug 8, 2025

About Panacea Biotec

Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Formulations segments. The company’s product portfolio includes prescription products in various therapeutic areas, such as transplantation, renal disease, oncology, respiratory, pain management, diabetes and cardiovascular management, gastro-intestinal care, nephrology, osteoporosi...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1984
• Employees: 1,936
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531349

Financial Performance

In 2024, Panacea Biotec's revenue was 5.59 billion, a decrease of -0.01% compared to the previous year's 5.59 billion. Losses were -83.70 million, 613.6% more than in 2023.